agilon health

Aging Population And Value-Based Care Will Expand Opportunities

AnalystHighTarget

Not Invested

Community Contributor

Published

06 Aug 25

AnalystHighTarget's Fair Value

US$3.60

71.7% undervalued

10 Sep

US$1.02

-69.3%

-5.6%

-69.3%

-5.6%

You can edit this narrative until Aug 6 9:17 PM. Then, changes will post as Updates.

Author's Valuation

US$3.671.7% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$3.6

71.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

8.67%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.78%

Calculation

US$11.72m

Earnings '28

157.55x

PE Ratio '28

US$1.85b

Market Cap '28

US$1.85b

Market Cap '28

421.72m

No. shares '28

US$4.38

Share Price '28

US$4.38 Share Price '28

Discounted to 2025 @ 6.78% p.a.

US$3.60

Fair Value '25